Medical Informatics applied in psoriasis diagnosis and management

Hangan, L.T.; Capatana, D.; Nicola, Gh.; Chirila, S.; Gurgas, L.; Cambrea, Simona Claudia

doi:10.1515/arsm-2016-0011

Abstract

Psoriasis represents a chronic disease, with a prevalence of 0.91% to 8.5% worldwide. The clinical manifestations of the disease vary a lot from patient to patient and the response to treatment also varies a lot.

Today, in spite of the drawbacks it has, PASI (Psoriasis Area Severity Index) represents one of the best tools used to evaluate the extent of the disease and the response to medication.

One of the drawbacks of using this scoring system is considered to be the way a doctor has to calculate the result. In this study we offer, step by step, a possible solution to create an informatics tool that can offer the result of the score based on the inputs made by the doctor.

References

1. Parisi, R., Symmons, D.P.M., Griffiths, C.E.M. & Ashcroft, D.M. (2013). Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence. J Invest Dermatol. 133(2), 377-385. doi: http://www.nature.com/jid/journal/v133/n2/suppinfo/jid2012339s1.html10.1038/jid.2012.33923014338
Search in Google Scholar
2. Meffert, J. & James, W.D. (2015, December). Psoriasis Clinical Presentation. Retrieved December, 2015, from http://emedicine.medscape.com/article/1943419-clinical#showall
Search in Google Scholar
3. Naldi, L., Svensson, A., Diepgen, T., Elsner, P., Grob, J.J., Coenraads, P.J., Bavinck, J.N., Williams, H. & European Dermato- Epidemiology, N. (2003). Randomized clinical trials for psoriasis 1977-2000: the EDEN survey. J Invest Dermatol. 120(5), 738-741. doi: 10.1046/j.1523-1747.2003.12145.x10.1046/j.1523-1747.2003.12145.x12713574
Search in Google Scholar
4. Fredriksson, T. & Pettersson, U. (1978). Severe psoriasis--oral therapy with a new retinoid. Dermatologica. 157(4), 238-244.10.1159/000250839357213
Search in Google Scholar
5. Youn, S.W., Choi, C.W., Kim, B.R. & Chae, J.B. (2015). Reduction of Inter-Rater and Intra-Rater Variability in Psoriasis Area and Severity Index Assessment by Photographic Training. Annals of Dermatology. 27(5), 557-562. doi: 10.5021/ ad.2015.27.5.55710.5021/ad.2015.27.5.557462289026512170
Search in Google Scholar
6. Carlin, C.S., Feldman, S.R., Krueger, J.G., Menter, A. & Krueger, G.G. (2004). A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis. J Am Acad Dermatol. 50(6), 859-866. doi: 10.1016/j. jaad.2003.09.014
Search in Google Scholar
7. Harari, M., Shani, J., Hristakieva, E., Stanimirovic, A., Seidl, W. & Burdo, A. 2000). Clinical evaluation of a more rapid and sensitive Psoriasis Assessment Severity Score (PASS), and its comparison with the classic method of Psoriasis Area and Severity Index (PASI), before and after climatotherapy at the Dead-Sea. Int J Dermatol. 39(12), 913-918.10.1046/j.1365-4362.2000.00017.x11168660
Search in Google Scholar
8. Evidence Update Advisory Group. (2014). Psoriasis - Evidence Update November 2014 The assessment and management of psoriasis (Vol. 68). National Institute for Health and Care Excellence.
Search in Google Scholar
9. Ihtatho, D., Fadzil, M.H., Affandi, A.M. & Hussein, S.H. (2007). Area assessment of psoriasis lesion for PASI scoring. Conf Proc IEEE Eng Med Biol Soc. 2007, 3446-3449. doi: 10.1109/IEMBS.2007.435307210.1109/IEMBS.2007.435307218002738
Search in Google Scholar
10. Ahmad Fadzil, M.H., Ihtatho, D., Mohd Affandi, A. & Hussein, S.H. (2009). Objective assessment of psoriasis erythema for PASI scoring. J Med Eng Technol. 33(7), 516-524. doi: 10.1080/0743461090274407410.1080/0743461090274407419639508
Search in Google Scholar
11. Henseler, T. & Schmitt-Rau, K. (2008). A comparison between BSA, PASI, PLASI and SAPASI as measures of disease severity and improvement by therapy in patients with psoriasis. Int J Dermatol. 47(10), 1019-1023. doi: 10.1111/j.1365-4632.2008.03753.x10.1111/j.1365-4632.2008.03753.x18986347
Search in Google Scholar
12. Gottlieb, A.B., Chaudhari, U., Baker, D.G., Perate, M. & Dooley, L.T. (2003). The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician’s Global Assessment (PGA): a comparison. J Drugs Dermatol. 2(3), 260-266.
Search in Google Scholar
13. Nast, A., Gisondi, P., Ormerod, A.D., Saiag, P., Smith, C., Spuls, P.I., Arenberger, P., Bachelez, H., Barker, J., Dauden, E., de Jong, E.M., Feist, E., Jacobs, A., Jobling, R., Kemeny, L., Maccarone, M., Mrowietz, U., Papp, K.A., Paul, C., Reich, K., Rosumeck, S., Talme, T., Thio, H.B., van de Kerkhof, P., Werner, R.N. & Yawalkar, N. (2015). European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol. 29(12), 2277-2294. doi: 10.1111/jdv.1335410.1111/jdv.1335426481193
Search in Google Scholar
14. Bhor, U. & Pande, S. (2006). Scoring systems in dermatology. Indian J Dermatol Venereol Leprol. 72(4), 315-321. 10.4103/0378-6323.2672216880586
Search in Google Scholar

Medical Informatics applied in psoriasis diagnosis and management

Abstract

Paradigm

My account